Intrathecal Stem Cell Injection Treatment
The Intrathecal Stem Cell Injection Treatment is done to get stem cells directly to the spinal fluid and then cerebral fluid.
An intrathecal stem cell Injection treatment is similar to a spinal tap, except that we are not taking spinal fluid out, but putting 50 million mesenchymal stem cells in. This treatment will be part of our new protocol for MS, Parkinson’s, Alzheimer’s/Dementia, Stroke and Autism. To do this, we have brought on Dr. Torres who is an anesthesiologist.
Dr. Jose Salvador Torres Prado graduated med school at the University of Guadalajara and then did his Specialty in Anesthesiology there. He has worked in Spain and Mexico as an anesthesiologist over the past 8 years. Here in Mexico only anesthesiologists are allowed to perform intrathecal injections for safety reasons.
This new treatment will be used in conjunction with the stem cell IV and Nebulized Stem Cell Therapy.
Intrathecal Stem Cell Injection Treatment Process
- We start with a full blood analysis the day before treatment
- The clinic room is fully sterilized and then the patients back is sterilized with iodine and microdasyn.
- Dr. Torres and Nurse Marta prepare the syringe with 50 million mesenchymal stem cells
- Dr. Torres injects into the spinal fluid
Side Effects or Risks
The only side effects that have been documented are the following:
- 1 in 100 people will experience a slight fever for a few hours after treatment
- Most patients will have a headache a few hours after treatment or the next day. We provide tramacet and tylenol to help reduce or eliminate this side effect.
- Any injection treatment has a very small risk of infection. We do everything in a sterile environment with sterile equipment to take this risk to almost zero.
Dr. Torres has over 8 years performing intrathecal injections and our lab has over 8 years specializing in Mesenchymal Stem Cell research. See Stem Cell Certification by Clicking Here.
Intrathecal Stem Cell Injection Treatment Studies
There have been a lot of studies done on intrathecal stem cell injection treatments. As you will see below these treatments have been very successful which is why we offer this.
- Therapeutic Use of Intrathecal Mesenchymal Stem Cells in patients with Multiple Sclerosis
- Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis
Intrathecal Stem Cell Injection Treatment for MS Studies
- Cell-based therapeutic strategies for multiple sclerosis
- Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondaryprogressive multiple sclerosis: A triple blinded, placebo controlled, randomizedphase I/II safety and feasibility study
- Safety and efficacy of stem cell therapy for treatment of neural damage in patients with multiple sclerosis
- Autologous Mesenchymal Stem Cell Transplantation in Multiple Sclerosis: A Meta-Analysis
- Intranasally Administered Human MSC-Derived Extracellular Vesicles Pervasively Incorporate into Neurons and Microglia in both Intact and Status Epilepticus Injured Forebrain
- Therapeutic Application of Mesenchymal Stem Cells Derived Extracellular Vesicles for Immunomodulation
- Immunomodulatory effects of human umbilical cord Whartons jelly-derived mesenchymal stem cells on differentiation maturation and endocytosis of monocyte-derived dendritic cells
- The immunosuppressive potential of mesenchymal stem cells
Intrathecal Stem Cell Injected Treatment for Alzheimer’s Disease Studies
- Progressive increase in brain glucose metabolism after intrathecal administration of autologous mesenchymal stromal cells in patients with diffuse axonal injury
- Intrathecal cell therapy with autologous stromal cells increases cerebral glucose metabolism and can offer a new approach to the treatment of Alzheimer’s type dementia
- Intrathecal Injection in A Rat Model: A Potential Route to Deliver Human Wharton’s Jelly-Derived Mesenchymal Stem Cells into the Brain
Intrathecal Stem Cell Injected Treatment for Autism Disease Studies
- Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism